skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
12/10/2019
Application #:
15736663
Filing Dt:
12/14/2017
Publication #:
Pub Dt:
06/28/2018
Inventors:
Xavier SAELENS, Bert SCHEPENS, Iebe ROSSEY, Barney GRAHAM, Jason MCLELLAN, Morgan GILMAN
Title:
IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN ANTIBODY AGAINST RSV PREFUSION F PROTEIN
Assignment: 1
Reel/Frame:
045616/0685Recorded: 03/16/2018Pages: 10
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
01/24/2018
Exec Dt:
01/24/2018
Exec Dt:
01/25/2018
Assignees:
RIJVISSCHESTRAAT 120
GENT, BELGIUM 9052
SINT-PIETERSNIEUWSTRAAT 25
GENT, BELGIUM 9000
Correspondent:
LATHROP GAGE LLP
28 STATE STREET
7TH FLOOR
BOSTON, MA 02109
Assignment: 2
Reel/Frame:
045251/0156Recorded: 03/16/2018Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
01/30/2018
Assignee:
OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH
6011 EXECUTIVE BOULEVARD, SUITE 325, MSC 7660
BETHESDA, MARYLAND 20892-7660
Correspondent:
LATHROP GAGE LLP
28 STATE STREET
SUITE 700
BOSTON, MA 02109
Assignment: 3
Reel/Frame:
045616/0808Recorded: 03/16/2018Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
02/14/2018
Exec Dt:
02/14/2018
Assignee:
11 ROPE FERRY ROAD
HANOVER, NEW HAMPSHIRE 03755
Correspondent:
LATHROP GAGE LLP
28 STATE STREET
SUITE 700
BOSTON, MA 02109

Search Results as of: 05/02/2024 11:37 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT